MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202637069956 A) filed by Oncospear Aps on June 04, 2026, for Anti-Cd163 Antibodies With Improved Adcc Capabilities.
Inventors include Graversen, Niels Jonas Heilskov; Jensen, Maria Pauladottir; Strauss, Line Moesgaard; Hgh, Rikke Illum; Moulin, Morgane Jennifer; Skytthe, Maria Kljgaard; and Etzerodt, Anders.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present disclosure relates to improved antibodies targeting CD163. In particular, the present disclosure relates to improved antibodies targeting CD163 with improved capabilities in relation to inducing Antibody-Dependent Cell-mediated Cytotoxicity (ADCC).
Disclaimer: Curated by HT Syndication.
